Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5;15(4):922.
doi: 10.3390/v15040922.

Comparing Clinical Outcomes of COVID-19 and Influenza-Induced Acute Respiratory Distress Syndrome: A Propensity-Matched Analysis

Shiza Virk  1 , Mohammed A Quazi  2 , Adeel Nasrullah  3 , Aaisha Shah  1 , Evan Kudron  4 , Prabal Chourasia  5 , Anam Javed  1 , Priyanka Jain  4 , Karthik Gangu  6 , Tariq Cheema  3 , Briana DiSilvio  3 , Abu Baker Sheikh  4
Affiliations

Comparing Clinical Outcomes of COVID-19 and Influenza-Induced Acute Respiratory Distress Syndrome: A Propensity-Matched Analysis

Shiza Virk et al. Viruses. .

Abstract

Acute respiratory distress syndrome (ARDS) is one the leading causes of mortality and morbidity in patients with COVID-19 and Influenza, with only small number of studies comparing these two viral illnesses in the setting of ARDS. Given the pathogenic differences in the two viruses, this study shows trends in national hospitalization and outcomes associated with COVID-19- and Influenza-related ARDS. To evaluate and compare the risk factors and rates of the adverse clinical outcomes in patients with COVID-19 associated ARDS (C-ARDS) relative to Influenza-related ARDS (I-ARDS), we utilized the National Inpatient Sample (NIS) database 2020. Our sample includes 106,720 patients hospitalized with either C-ARDS or I-ARDS between January and December 2020, of which 103,845 (97.3%) had C-ARDS and 2875 (2.7%) had I-ARDS. Propensity-matched analysis demonstrated a significantly higher in-hospital mortality (aOR 3.2, 95% CI 2.5-4.2, p < 0.001), longer mean length of stay (18.7 days vs. 14.5 days, p < 0.001), higher likelihood of requiring vasopressors (aOR 1.7, 95% CI 2.5-4.2) and invasive mechanical ventilation (IMV) (aOR 1.6, 95% CI 1.3-2.1) in C-ARDS patients. Our study shows that COVID-19-related ARDS patients had a higher rate of complications, including higher in-hospital mortality and a higher need for vasopressors and invasive mechanical ventilation relative to Influenza-related ARDS; however, it also showed an increased utilization of mechanical circulatory support and non-invasive ventilation in Influenza-related ARDS. It emphasizes the need for early detection and management of COVID-19.

Keywords: ARDS; COVID-19; Influenza; National Inpatient Sample; mechanical ventilation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Geographic distribution of ARDS patients with COVID-19 and Influenza in the United States.
Figure 2
Figure 2
In hospital outcomes in COVID ARDS versus Influenza ARDS.
Figure 3
Figure 3
Distribution of disposition of Influenza ARDS in National Inpatient Discharges in 2020.
Figure 4
Figure 4
Mortality predictors in COVID-19 patients (multivariate analysis).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. CDC COVID Data Tracker. [(accessed on 2 March 2023)]; Available online: https://covid.cdc.gov/covid-data-tracker/#trends_totalcases_select_00.
    1. Solomon D.A., Sherman A.C., Kanjilal S. Influenza in the COVID-19 Era. JAMA. 2020;324:1342–1343. doi: 10.1001/jama.2020.14661. - DOI - PubMed
    1. NIS Database Documentation. [(accessed on 25 November 2022)]; Available online: https://hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
    1. Tzotzos S.J., Fischer B., Fischer H., Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: A global literature survey. Crit. Care. 2020;24:516. doi: 10.1186/s13054-020-03240-7. - DOI - PMC - PubMed
    1. Christie A., Henley S.J., Mattocks L., Fernando R., Lansky A., Ahmad F.B., Adjemian J., Anderson R.N., Binder A.M., Carey K., et al. Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine—United States, September 6, 2020–May 1, 2021. Morb. Mortal. Wkly. Rep. 2021;70:858–864. doi: 10.15585/mmwr.mm7023e2. - DOI - PMC - PubMed

MeSH terms